Table:
begin	end	state
1	20	cytoplasmic
21	42	transmembrane
43	50	non-cytoplasmic
51	74	transmembrane
75	96	cytoplasmic
97	123	transmembrane
124	128	non-cytoplasmic
129	148	transmembrane
149	158	cytoplasmic
159	181	transmembrane
182	203	non-cytoplasmic
204	227	transmembrane
228	246	cytoplasmic
247	266	transmembrane
267	285	non-cytoplasmic
286	310	transmembrane
311	336	cytoplasmic
337	358	transmembrane
359	363	non-cytoplasmic
364	389	transmembrane
390	408	cytoplasmic
409	430	transmembrane
431	435	non-cytoplasmic
436	454	transmembrane
455	469	cytoplasmic

Input:
>WP_084936496.1 NCBI__GCF_002095475.1:WP_084936496.1
MQTQETPSQDNFKRTMKVRHLVMLSLGGVIGTGLFFNTGYIISTTGAAGTLLAYLIGALV
VWLVMVCLGELAVAMPETGAFHVYAARYLSPATGYTVAWLYWLTWTVALGSSLTAAGFCM
QYWFPTTPVWLWCLVFCIAIYLLNIVSTRFFAEGEFWFSIIKVVTIIAFIILGAGAMFGF
IPMKDGSAAPGLSNLTASGWLPHGTLPILMTMVAVNFAFSGTELIGIAAGETEQPQKALP
LAIRTTVARLIIFFIGTVFVLAALIPMDQAGIVKSPFVLVFEKIGIPYAADIFNFVILTA
ILSAANSGLYASGRMLWSLANENTLPRCFARVNHRGVPVLALTISMLGGLLALFSSVIAP
DTVFVALSAISGFAVVAVWLSICASHYVFRRRHLQAGGTLQQLAYRAPLYPLTPILGFLL
CLLACVGLAFDPSQRIALWCGIPFVLFCYAAYHVTHRRNLKAGEANDVA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server